Brief clinical and laboratory observationNeonatal thyrotoxicosis: Intellectual impairment and craniosynostosis in later years
References (10)
- et al.
Premature synostosis: A complication of thyroid replacement therapyy
J Pediatr
(1975) - et al.
Premature craniosynostosis: A common complication of juvenile thyrotoxicosis
J Pediatr
(1978) A foetus with congenital hereditary Graves' disease
J Obstet Gynaecol Br Emp
(1912)- et al.
Congenital Graves' disease
Am J Dis Child
(1976) Neonatal Graves' disease
J Clin Endocrinol Metab
(1964)
Cited by (154)
Neonatal Endocrine Diseases
2023, Emergency Medicine Clinics of North AmericaNeonatal Thyroid Disease
2023, Principles of NeonatologyRole of thyroid hormones in normal and abnormal central nervous system myelination in humans and rodents
2021, Frontiers in NeuroendocrinologyCitation Excerpt :Even though studies on excessive T4 levels during gestation or overtreatment of hypothyroidism have often reported concomitant neurodevelopmental impairments in females and males (Daneman and Howard, 1980; Kopelman, 1983; Bongers-Schokking and de Muinck Keizer-Schrama, 2005), the neurological impacts of CHE are not fully understood. Preclinical studies have revealed that while congenital (Daneman and Howard, 1980) and postnatal (Salas-Lucia et al., 2020) hypothyroidism is accompanied by reductions in WM and altered corpus callosum maturation, neonatal hyperthyroidism is associated with accelerated myelin development (Walters and Morell, 1981; Marta et al., 1998), similar to the accelerated hypermyelination seen in TTR null studies. However, the proportion of males and females distributed in each group was not mentioned in these studies.
Management of neonates born to mothers with thyroid dysfunction, and points for attention during pregnancy
2020, Best Practice and Research: Clinical Endocrinology and MetabolismCitation Excerpt :In addition to disease-related abnormal maternal TH concentrations influencing embryonic/early fetal TH levels, (early) fetal and neonatal thyroid function and TH levels can be disturbed by maternal thyroid autoantibodies, and by antithyroid drugs used by the mother for the treatment of hyperthyroidism. Because of considerable morbidity and even fatal outcome, fetal and neonatal hyperthyroidism are considered serious conditions, even though well-designed observational studies on their clinical and developmental outcome are lacking [11–13]. This review focusses on the consequences of maternal hypo- and hyperthyroidism for fetus and neonate, and provides a practical approach to the clinical management of neonates born to mothers with thyroid dysfunction.
Thyroid Disorders in Children and Adolescents
2020, Sperling Pediatric Endocrinology: Expert Consult - Online and PrintCurrent knowledge about the in utero and peripartum management of fetal goiter associated with maternal Graves’ disease
2019, European Journal of Obstetrics and Gynecology and Reproductive Biology: XCitation Excerpt :Fetal hyperthyroidism can cause fetal growth restriction (FGR) which is accompanied by accelerated bone maturation, goiter development, and craniosynostosis. Thyrotoxicosis, comprising tachycardia, cardiac failure, and hydrops, can occur, which may cause premature birth, intrauterine or perinatal death, or serious neurological sequelae [10]. Fetal hypothyroidism is associated with retarded skeletal development, mental retardation, hearing defects, poor visuomotor abilities, delayed speech and language development, and poor attention and memory skills [11].